Parag Das - Tata Translational Cancer Research Centre, Tata Medical Centre

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 17 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Hybrid Email and Outpatient Clinics to Optimize Maintenance Therapy in Acute Lymphoblastic Leukemia

Tushar Mungle, Ananya Mahadevan,Parag Das, Amit K. Mehta,Manash P. Gogoi,Bishwaranjan Jana,Niharendu Ghara,Debjani Ghosh,Vaskar Saha,Shekhar Krishnan

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGYno. 1 (2024): 39-45

引用0浏览0WOS引用

Advanced retinoblastoma with excellent treatment outcome despite challenges- a report from eastern india

Arpita Bhattacharyya,Anirban Das,Anirban Bhaduri, Kalpita Das, Jasmin Khatun,Parag Das, Bikramjit Pal,Reghu Ks

PEDIATRIC BLOOD & CANCER (2023)

引用0浏览0引用

Parag Das, Aravind Sridhar,Nandana Das

Pediatric Hematology Oncology Journalno. 4 (2023): S59

引用0浏览0引用

Delayed Intensification Including Venetoclax and Bortezomib Prolongs Survival in Very High Risk Acute Lymphoblastic Leukaemia

Jasmeet Sidhu, Arijit Chakraborty,Parag Das,Manash Pratim Gogoi, Tanima Dey,Fabio D. Steffen,Sangramjit Basu,Debdutta Ganguli,Debjani Ghosh,Niharendu Ghara, Subhajit Kundu, Abhirupa Kar,Beat Bornhauser,Jean-Pierre Bourquin,Vaskar Saha,Shekhar Krishnan

Bloodno. Supplement 1 (2023): 4244-4244

引用0浏览0引用

Drug Response Profiling Identifies Sensitive Synergistic Drug Combinations for Patients with Refractory/relapsed Acute Lymphoblastic Leukemia

Jasmeet Sidhu, Shruti Banerjee, Arko Bhowal,Parag Das,Manash Pratim Gogoi,Ritam Siddhanta, Kankana Das,Niharendu Ghara,Pritha Paul,Shekhar Krishnan,Vaskar Saha

Pediatric hematology oncology journalno. 4 (2022): S2-S2

引用0浏览0引用

High treatment related mortality due to infection remains a major challenge in the management of high-grade B-cell Non-Hodgkin Lymphoma in children in developing countries: Experience from a tertiary cancer center in Eastern India

Avijeet Kumar Mishra,Shekhar Krishnan,Arpita Bhattacharyya,K.S. Reghu,Anirban Das,Sheetal Kulkarni Modi,Parag Das,Niharendu Ghara

Pediatric Hematology Oncology Journal（2022）

引用4浏览0引用

Protocol for ICiCLe-ALL-14 (Inpog-All-15-01): a Prospective, Risk Stratified, Randomised, Multicentre, Open Label, Controlled Therapeutic Trial for Newly Diagnosed Childhood Acute Lymphoblastic Leukaemia in India

Das Nandana, Homi Bhabha National Institute,Bakhshi Sameer,Trehan Amita,Radhakrishnan Venkatraman,Seth Rachna,Sinha Subir,Roy Prakriti,Gogoi Manash Pratim, Chatterjee Sayan, Abraham Bindhu,Das Parag,University of Manchester

Trials（2022）

引用22浏览0WOS引用

Early Experience with Blinatumomab in B-cell Precursor (BCP) Acute Lymphoblastic Leukaemia (ALL) at the Tata Medical Center (TMC), Kolkata

Debjani Ghosh,Parthasarathi Bhattacharyya, Sangeeta Choini,Manik Ghost,Samik Samaddar,Parag Das,Nandana Das,Vaskar Saha,Shekhar Krishnan,Niharendu Ghara

Pediatric Hematology Oncology Journal (2022)

引用0浏览0引用

Comparative Treatment Costs of Risk‐stratified Therapy for Childhood Acute Lymphoblastic Leukemia in India

Tushar Mungle,Nandana Das,Saikat Pal,Manash Pratim Gogoi,Parag Das,Niharendu Ghara,Debjani Ghosh,Ramandeep Singh Arora,Nickhill Bhakta,Vaskar Saha,Shekhar Krishnan

Cancer medicine（2022）

引用0浏览0WOS引用

IMPACT OF SARS-COV-2 PANDEMIC ON TREATMENT INITIATION AND DELIVERY IN CHILDREN WITH CANCER

Arpita Bhattacharyya,Sanjay Bhattacharya,Gaurav Goel, Jasmin Khatun,Parag Das,Shekhar Krishnan

PEDIATRIC BLOOD & CANCER（2022）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn